Coronavirus Vaccine / University of Saskatchewan, ZYUS - LARVOL DELTA

ZYUS Announces Positive Milestone in Plant-Based COVID-19 Vaccine Antigen Production (Businesswire) - "ZYUS Life Sciences...announced today that it has reached a positive milestone in the development of COVID-19 vaccine components by achieving plant-based expression, isolation, and purification of a potential antigen for a SARS-CoV-2 vaccine....Tested and demonstrated that the plant-based SARS-CoV-2 protein is recognised by antibodies in the serum of recovered COVID-19 patients, suggesting that plant-based protein, in this form of a vaccine, could potentially provide protection from COVID-19 infection."

Preclinical • Infectious Disease • Novel Coronavirus Disease